Home > Financial Ratios > VENUS REMEDIES

VENUS REMEDIES
EV/Core EBITDA

    Back to All Ratios
VENUS REMEDIES is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for VENUS REMEDIES
Please provide your vote to see the results

VENUS REMEDIES Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   EV/Core EBITDA(x) 6.723.815.752.905.00

What is the latest EV/Core EBITDA ratio of VENUS REMEDIES ?

The latest EV/Core EBITDA ratio of VENUS REMEDIES is 6.72 based on Mar2026 Consolidated results.
Year EV/Core EBITDA
Mar20266.72
Mar20253.81
Mar20245.75
Mar20232.90
Mar20225.00

How is EV/Core EBITDA of VENUS REMEDIES Trending?

Years EV/Core EBITDA % Change
Mar2026 6.72
76.38
Mar2025 3.81
-33.74
Mar2024 5.75
98.28
Mar2023 2.9
-42.00
Mar2022 5 -

Other Financial Ratios of VENUS REMEDIES


Compare EV/Core EBITDA ratio of peers of VENUS REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
VENUS REMEDIES ₹2,407.2 Cr 10.4% 8.1% 282.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹436,679.0 Cr -1.8% -7% 14.3% Stock Analytics
DIVIS LABORATORIES ₹246,408.0 Cr -3.4% 0.4% 58.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹182,634.0 Cr -2.7% -3.6% 36% Stock Analytics
CIPLA ₹109,063.0 Cr -3.9% -4.7% -10.1% Stock Analytics
DR REDDYS LABORATORIES ₹103,166.0 Cr 3% 6.1% -3.8% Stock Analytics


VENUS REMEDIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
VENUS REMEDIES

10.4%

8.1%

282.5%

SENSEX

-3.1%

-6.2%

-11.7%


You may also like the below Video Courses